Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$538M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 3 |
RTX Corp
RTX
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$332M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Compass Minerals
CMP
$1.25B
| $10.3M | ﹤0.01% |
152,461
+49,008
| +47% | +$3.73M |
|
|
XENT
2127
DELISTED
Intersect ENT, Inc
XENT
| $10.3M | ﹤0.01% |
602,499
+27,550
| +5% | +$386K |
|
2128
Portland General Electric
POR
$5.89B
| $10.3M | ﹤0.01% |
232,464
-244,092
| -51% | -$10.7M |
|
2129
KB Financial Group
KB
$42.1B
| $10.3M | ﹤0.01% |
234,302
+30,240
| +15% | +$1.25M |
|
|
MGP
2130
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $10.3M | ﹤0.01% |
380,695
-311,213
| -45% | -$7.98M |
|
2131
HUB Group
HUBG
$2.92B
| $10.3M | ﹤0.01% |
443,844
+127,484
| +40% | +$3.01M |
|
|
MTGE
2132
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $10.3M | ﹤0.01% |
614,514
-79,571
| -11% | -$1.3M |
|
|
NRE
2133
DELISTED
NorthStar Realty Europe Corp.
NRE
| $10.3M | ﹤0.01% |
887,797
+290,839
| +49% | +$3.52M |
|
2134
Signet Jewelers
SIG
$3.78B
| $10.3M | ﹤0.01% |
148,486
+38,074
| +34% | +$2.85M |
|
|
DOG
2135
ProShares Short Dow30
DOG
$97.1M
| $10.3M | ﹤0.01% |
142,018
-30,839
| -18% | -$2.27M |
|
2136
Rambus
RMBS
$10.9B
| $10.3M | ﹤0.01% |
781,764
-112,825
| -13% | -$1.48M |
|
2137
BlackRock MuniYield Quality Fund III
MYI
$716M
| $10.3M | ﹤0.01% |
737,244
-126,308
| -15% | -$1.74M |
|
2138
Dr. Reddy's Laboratories
RDY
$10.1B
| $10.3M | ﹤0.01% |
1,278,485
+54,165
| +4% | +$468K |
|
|
AMRI
2139
DELISTED
Albany Molecular Research Inc
AMRI
| $10.3M | ﹤0.01% |
731,638
+115,040
| +19% | +$1.88M |
|
|
ALDW
2140
DELISTED
Alon USA Partners LP
ALDW
| $10.2M | ﹤0.01% |
1,116,396
+787,330
| +239% | +$7.75M |
|
|
AAV
2141
DELISTED
Advantage Oil & Gas Ltd
AAV
| $10.2M | ﹤0.01% |
1,548,511
+537,472
| +53% | +$3.38M |
|
|
CONN
2142
DELISTED
Conn's Inc.
CONN
| $10.2M | ﹤0.01% |
1,167,215
-461,133
| -28% | -$4.64M |
|
2143
Cooper Companies
COO
$14.6B
| $10.2M | ﹤0.01% |
204,280
+44,516
| +28% | +$2.11M |
|
2144
Ormat Technologies
ORA
$6.15B
| $10.2M | ﹤0.01% |
178,709
-28,657
| -14% | -$1.59M |
|
2145
GATX Corp
GATX
$6.42B
| $10.2M | ﹤0.01% |
167,012
-39,198
| -19% | -$2.31M |
|
2146
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $10.2M | ﹤0.01% |
100,332
+10,325
| +11% | +$1.04M |
|
|
CLVS
2147
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.2M | ﹤0.01% |
159,536
-25,062
| -14% | -$1.52M |
|
|
WRI
2148
DELISTED
Weingarten Realty Investors
WRI
| $10.1M | ﹤0.01% |
303,632
-273,596
| -47% | -$9.55M |
|
|
IBMG
2149
DELISTED
iShares iBonds Sep 2018 Term Muni Bond ETF
IBMG
| $10.1M | ﹤0.01% |
398,446
-20,585
| -5% | -$524K |
|
|
HYI
2150
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
| $10.1M | ﹤0.01% |
659,811
-92,288
| -12% | -$1.41M |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.